Business Description
Organogenesis Holdings Inc. is a Canton, Massachusetts-based company that develops and sells a broad range of biological and bioengineered products designed to help heal wounds and support surgical recovery across the United States. Its portfolio includes skin substitutes, placental tissue grafts, antimicrobial barriers, and collagen-based materials used by hospitals, wound care centers, and physician offices to treat conditions such as diabetic foot ulcers, burns, and chronic wounds. The company also has a product in late-stage clinical trials aimed at relieving knee osteoarthritis symptoms, pointing to its ambitions beyond wound care.
